Where I see patients (2)
My reviews
Selected research
-
CDK12 Loss Promotes Prostate Cancer Development While Exposing Vulnerabilities to Paralog-Based Synthetic Lethality.
bioRxiv : the preprint server for biology
-
Initial Experience with 68Ga-FAP-2286 PET Imaging in Patients with Urothelial Cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
-
Development of CD46 targeted alpha theranostics in prostate cancer using 134Ce/225Ac-Macropa-PEG4-YS5.
Theranostics
Contact me
- Request appointment
- Refer a patient
- (415) 476-4616
4.9